Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa.
about
Wide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency.Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update.Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
P2860
Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Gag-Protease Sequence Evolutio ...... es Circulating in East Africa.
@en
type
label
Gag-Protease Sequence Evolutio ...... es Circulating in East Africa.
@en
prefLabel
Gag-Protease Sequence Evolutio ...... es Circulating in East Africa.
@en
P2093
P2860
P50
P356
P1476
Gag-Protease Sequence Evolutio ...... es Circulating in East Africa.
@en
P2093
Adele McCormick
Anne Kapaata
Cissy Kityo
DART Trial Team
DART Virology Group
David Dunn
Fred Lyagoba
Geant Thiltgen
Katherine A Sutherland
Moira Spyer
P2860
P304
P356
10.1089/AID.2015.0138
P577
2015-08-10T00:00:00Z